Back to search

Azadyne Ltd

11740078

active
Private Limited Company
england wales
Companies House
Health Score
90 / 100

Healthy

30/30
Filing
20/30
Financial
40/40
Risk

No risk factors detected.

Details

101 NEW CAVENDISH STREET, LONDON, W1W 6XH
Incorporated 24/12/2018

Compliance

Last accounts

31/12/2025

total exemption full

Next accounts due

30/09/2027

On track

Confirmation statement

Last: 23/12/2025

Due 06/01/2027

On track

Industry

72110
Research and experimental development on biotechnology

Officers

Mr Jason Edward Rutt

director · Since 24/12/2018

DIRECTOR

BRITISH · ENGLAND · Age 55

Also on 2 other boards

Dr Stephen Joseph Connon

director · Since 21/02/2019

ACADEMIC

IRISH · IRELAND · Age 50

Mr Jonathan Stuart Synett

director · Since 13/05/2019

COMPANY DIRECTOR

BRITISH · ENGLAND · Age 49

Also on 15 other boards

Mr Paul Michael Tselentis

director · Since 10/11/2022

CHIEF EXECUTIVE OFFICER

BRITISH,GREEK,SOUTH AFRICAN · ENGLAND · Age 46

Also on 3 other boards

Persons with Significant Control

Mr Jason Edward Rutt

Appoint directors

British · England · Age 55

101, New Cavendish Street, London, W1W 6XH

Notified 23/12/2019

Former PSCs

Mr Stephen Joseph Cannon

Ceased 20/02/2019

Mr Vincent Patrick Kelly

Ceased 20/02/2019

Mr John Michael Southern

Ceased 20/02/2019

CompanyRankvs 379+ SIC 72110 peers
76

Financial strength91th percentile among SIC peers · 23/25
Employees66th percentile among SIC peers · 10/15
LiquidityCurrent ratio 10.3× · 20/20
Longevity8 years trading (max 15) · 8/15
Filing complianceAll filings up to date · 15/15
Show leaderboard
1Charles River U.K. Limited
90
2Werfen Limited
90
3Biopharma Process Systems Limited
90
4Theradex (Europe) Limited
90
5Spicer Consulting Limited
90
6Exmoor Pharma Concepts Limited
90
7Ubc Late Stage (Uk) Limited
90
8Wuxi Apptec Uk Ltd
90
9Ccm Technologies Limited
90
10Bio - Diagnostics Limited
89
379Azadyne Ltd
75
How is this score calculated?
Financial strength23/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees10/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity20/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity8/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Key FinancialsYear ending 31/12/2025

Net Worth

£719k

Balance sheet strength

Cash

£365k

Cash in the bank

Net Current Assets

£415k

Working capital

Current Assets

£460k

Current Liabilities

£45k

Fixed Assets

£304k

Debtors

£95k

2avg. employees-1

Balance Sheet

Intangible assets£303k
Assets less current liabilities£719k
Prepared with Caseware UK (AP4) 2025.0.111

EstimatesDerived

YearCurrent RatioImplied Profit
202510.30-£220k
202414.27+£592
20234.57—

Derived from filed accounts. Not audited figures.